{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:22:33Z","timestamp":1787026953421,"version":"build-2736575974"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Zhengjiang Municipal Science and Technology Plan for Social Development -Frontier Technologies","award":["SH2024004"],"award-info":[{"award-number":["SH2024004"]}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Metabolic dysfunction-associated fatty liver disease (MAFLD) represents a prevalent chronic hepatic condition globally, characterized by hepatic steatosis concurrent with at least one cardiometabolic risk factor, such as overweight\/obesity, type 2 diabetes mellitus (T2DM), or metabolic dysregulation. This study aimed to evaluate the associations between nine non-conventional lipid parameters\u2014BMI, NHHR, AIP, RC, GHR, CHG, LCI, TyG, TyG-BMI\u2014and MAFLD, and to compare their predictive performance for MAFLD screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study utilized the electronic medical record at Wuhan Union Hospital between January 2020 and November 2021, and multi-model adjustment weighted logistic regression analysis was applied to investigate the association of the nine parameters with MAFLD. Receiver operating characteristic (ROC) curves were analyzed to assess the screening ability of the nine parameters. Furthermore, the association between the most predictive parameter and MAFLD was investigated with RCS analysis, and differences in risk across populations were explored with subgroup analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 1,592 participants were included in the final analysis, among whom 937 (58.86%) were diagnosed with MAFLD. Multivariable logistic regression identified NHHR, BMI, AIP, RC, GHR, LCI, TyG, and TyG-BMI as independent risk factors for MAFLD, with TyG-BMI demonstrating the strongest association (OR\u202f=\u202f3.7, 95% CI: 3.05\u20134.48). The area under the ROC curve (AUC) for TyG-BMI was 0.81, and its predictive performance was significantly superior to that of the other parameters (all\n                      <jats:italic>P<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001 by DeLong\u2019s test). RCS analysis revealed a nonlinear relationship between TyG-BMI and MAFLD (\n                      <jats:italic>P<\/jats:italic>\n                      for nonlinearity&amp;lt;0.001), with an identified inflection point at a TyG-BMI value of 222.426. Additionally, MAFLD patients in the highest TyG-BMI tertile exhibited a significantly increased risk of atherosclerotic cardiovascular disease (ASCVD) compared to those in the lowest tertile (OR\u202f=\u202f2.55, 95% CI: 1.337\u20134.91) after adjustment for confounders.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The evaluated non-conventional lipid parameters, particularly TyG-BMI, are useful indicators for MAFLD identification. TyG-BMI demonstrated the strongest predictive ability for MAFLD and was independently associated with ASCVD risk in affected individuals. Elevated TyG-BMI may therefore serve as a clinically accessible marker for identifying individuals at high risk of MAFLD and for stratifying cardiovascular risk in patients with established MAFLD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1788704","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:04:13Z","timestamp":1772003053000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["The development and evaluation of nine non-conventional lipid parameters for metabolic dysfunction-associated fatty liver disease in Chinese medical health examination adults: a single-center retrospective study"],"prefix":"10.3389","volume":"13","author":[{"given":"Lian","family":"Song","sequence":"first","affiliation":[{"name":"Department of Medical Imaging, Affiliated Hospital of Jiangsu University","place":["Zhenjiang, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Affiliated Hospital of Jiangsu University","place":["Zhenjiang, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinhui","family":"Hang","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Affiliated Hospital of Jiangsu University","place":["Zhenjiang, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijie","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Affiliated Hospital of Jiangsu University","place":["Zhenjiang, Jiangsu, China"]},{"name":"School of Medicine, Jiangsu University","place":["Zhenjiang, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Affiliated Hospital of Jiangsu University","place":["Zhenjiang, Jiangsu, China"]},{"name":"School of Medicine, Jiangsu University","place":["Zhenjiang, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongqing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Affiliated Hospital of Jiangsu University","place":["Zhenjiang, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","article-title":"The Asian Pacific Association for the Study of the liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease","volume":"14","author":"Eslam","year":"2020","journal-title":"Hepatol Int"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s12072-024-10774-3","article-title":"The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease","volume":"19","author":"Eslam","year":"2025","journal-title":"Hepatol Int"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.3748\/wjg.v28.i39.5691","article-title":"Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: epidemiology, pathophysiologic mechanisms, and treatment considerations","volume":"28","author":"Theofilis","year":"2022","journal-title":"World J Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"941","DOI":"10.21037\/hbsn-23-538","article-title":"An ever-increasing metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: what are problems and countermeasures?","volume":"12","author":"Shimose","year":"2023","journal-title":"Hepatobiliary Surg Nutr"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1053\/j.gastro.2021.04.074","article-title":"Preparing for the NASH epidemic: a call to action","volume":"161","author":"Kanwal","year":"2021","journal-title":"Gastroenterology"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.62347\/KMSA5983","article-title":"Non-alcoholic fatty liver disease: pathogenesis and models","volume":"16","author":"Zhong","year":"2024","journal-title":"Am J Transl Res"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1136\/gutjnl-2015-309265","article-title":"Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study","volume":"65","author":"Kwok","year":"2016","journal-title":"Gut"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2147\/DMSO.S342505","article-title":"Associations between GGT\/HDL and MAFLD: a cross-sectional study","volume":"15","author":"Xing","year":"2022","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12876-025-03659-8","article-title":"Potential predictive role of non-HDL to HDL cholesterol ratio (NHHR) in MASLD: focus on obese and type 2 diabetic populations","volume":"25","author":"Ma","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1405828","DOI":"10.3389\/fendo.2024.1405828","article-title":"Elevated AIP is associated with the prevalence of MAFLD in the US adults: evidence from NHANES 2017-2018","volume":"15","author":"Chen","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"954219","DOI":"10.3389\/fnut.2022.954219","article-title":"The atherogenic index of plasma: a novel factor more closely related to non-alcoholic fatty liver disease than other lipid parameters in adults","volume":"9","author":"Liu","year":"2022","journal-title":"Front Nutr"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"25985","DOI":"10.31083\/RCM25985","article-title":"Remnant cholesterol and residual risk of atherosclerotic cardiovascular disease","volume":"26","author":"Li","year":"2025","journal-title":"Rev Cardiovasc Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12933-025-02675-y","article-title":"Cholesterol, high-density lipoprotein, and glucose index versus triglyceride-glucose index in predicting cardiovascular disease risk: a cohort study","volume":"24","author":"Mo","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1683822","DOI":"10.3389\/fmed.2025.1683822","article-title":"Correction: correlation between ratio of fasting blood glucose to high density lipoprotein cholesterol in serum and non-alcoholic fatty liver disease in American adults: a population based analysis","volume":"12","author":"Jin","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12933-025-02768-8","article-title":"Association between atherogenicity indices and prediabetes: a 5-year retrospective cohort study in a general Chinese physical examination population","volume":"24","author":"Qiu","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e70071","DOI":"10.1002\/hsr2.70071","article-title":"Prevalence of metabolic dysfunction-associated steatotic liver disease in people living with HIV and on antiretroviral treatment: a systematic review and meta-analysis protocol","volume":"7","author":"Sedibe","year":"2024","journal-title":"Health Sci Rep"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/S2468-1253(24)00193-6","article-title":"Natural history and progression of metabolic dysfunction-associated steatotic liver disease","volume":"9","author":"Hagstr\u00f6m","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e072489","DOI":"10.1136\/bmjopen-2023-072489","article-title":"Association of fat-to-muscle ratio with non-alcoholic fatty liver disease: a single-Centre retrospective study","volume":"13","author":"Yan","year":"2023","journal-title":"BMJ Open"},{"key":"ref21","volume-title":"Association of fat-to-muscle ratio with non-alcoholic fatty liver disease: A single-Centre retrospective study","author":"Yan","year":"2023"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e 070189","DOI":"10.1136\/bmjopen-2022-070189","article-title":"Association between triglyceride glucose-related markers and the risk of metabolic-associated fatty liver disease: a cross- sectional study in healthy Chinese participants","volume":"13","author":"Chang","year":"2023","journal-title":"BMJ Open"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s12876-024-03471-w","article-title":"Association between the triglyceride to high density lipoprotein cholesterol ratio and the incidence of metabolic dysfunction- associated fatty liver disease: a retrospective cohort study","volume":"24","author":"Ma","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"12663","DOI":"10.1038\/s41598-024-63453-6","article-title":"Impact of metabolic phenotype and alcohol consumption on mortality risk in metabolic dysfunction-associated fatty liver disease: a population-based cohort study","volume":"14","author":"Charatcharoenwitthaya","year":"2024","journal-title":"Sci Rep"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3892\/etm.2020.9327","article-title":"Interactions between leptin and insulin resistance in patients with prediabetes, with and without NAFLD","volume":"20","author":"Bungau","year":"2020","journal-title":"Exp Ther Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3390\/metabo13060757","article-title":"Metabolic-associated fatty liver disease and insulin resistance: a review of complex interlinks","volume":"13","author":"Barber","year":"2023","journal-title":"Meta"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"3946320221137435","DOI":"10.1177\/03946320221137435","article-title":"Luteolin loaded on zinc oxide nanoparticles ameliorates non-alcoholic fatty liver disease associated with insulin resistance in diabetic rats via regulation of PI3K\/AKT\/FoxO1 pathway","volume":"36","author":"Ahmed","year":"2022","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12902-022-00984-x","article-title":"Predictive performance of lipid parameters in identifying undiagnosed diabetes and prediabetes: a cross-sectional study in eastern China","volume":"22","author":"Zhou","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"691556","DOI":"10.3389\/fendo.2021.691556","article-title":"Varied relationship of lipid and lipoprotein profiles to liver fat content in phenotypes of metabolic associated fatty liver disease","volume":"12","author":"Wu","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e047588","DOI":"10.1136\/bmjopen-2020-047588","article-title":"Prevalence and risk factors of metabolic-associated fatty liver disease during 2014-2018 from three cities of Liaoning Province: an epidemiological survey","volume":"12","author":"Guan","year":"2022","journal-title":"BMJ Open"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.2169\/internalmedicine.6574-20","article-title":"Impact of Pemafibrate in patients with hypertriglyceridemia and metabolic dysfunction-associated fatty liver disease pathologically diagnosed with non-alcoholic steatohepatitis: a retrospective, single-arm study","volume":"60","author":"Hatanaka","year":"2021","journal-title":"Intern Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.2147\/DMSO.S356371","article-title":"Lipid-lowering responses to Dyslipidemia determine the efficacy on liver enzymes in metabolic dysfunction- associated fatty liver disease with hepatic injuries: a prospective cohort study","volume":"15","author":"Liao","year":"2022","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e075413","DOI":"10.1136\/bmjopen-2023-07541","article-title":"Diagnostic value of triglyceride-glucose index and related parameters in metabolism-associated fatty liver disease in a Chinese population: a cross-sectional study","volume":"13","author":"Yu","year":"2023","journal-title":"BMJ Open"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1031259","DOI":"10.3389\/fonc.2022.1031259","article-title":"Triglyceride glucose index and atherogenic index of plasma for predicting colorectal neoplasms in patients without cardiovascular diseases","volume":"12","author":"Han","year":"2022","journal-title":"Front Oncol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12933-019-0957-3","article-title":"High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention","volume":"18","author":"Luo","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-019-0982-2","article-title":"Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients","volume":"19","author":"Alizargar","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2024.08.026","article-title":"Triglyceride glucose (TyG) index: a promising biomarker for diagnosis and treatment of different diseases","volume":"131","author":"Sun","year":"2025","journal-title":"Eur J Intern Med"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.2147\/DMSO.S383907","article-title":"Association between triglyceride-glucose index and risk of metabolic dysfunction-associated fatty liver disease: a cohort study","volume":"15","author":"Zhang","year":"2022","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12876-024-03579-z","article-title":"Association between the triglyceride-glucose index and liver fibrosis in adults with metabolism-related fatty liver disease in the United States: a cross-sectional study of NHANES 2017-2020","volume":"25","author":"Ying","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s40001-025-02373-1","article-title":"Risk factor analysis and predictive model construction of lean MAFLD: a cross-sectional study of a health check-up population in China","volume":"30","author":"Zhu","year":"2025","journal-title":"Eur J Med Res"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"e0212963","DOI":"10.1371\/journal.pone.0212963","article-title":"Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: An analysis of the 2007-2010 Korean National Health and nutrition examination survey","volume":"14","author":"Lim","year":"2019","journal-title":"PLoS One"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12933-025-02584-0","article-title":"Triglyceride-glucose-body mass index and the incidence of cardiovascular diseases: a meta-analysis of cohort studies","volume":"24","author":"Rao","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13098-024-01571-x","article-title":"Prediction of MASLD using different screening indexes in Chinese type 2 diabetes mellitus","volume":"17","author":"Hu","year":"2025","journal-title":"Diabetol Metab Syndr"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.3390\/nu14234969","article-title":"The diagnostic and prognostic value of the triglyceride-glucose index in metabolic dysfunction-associated fatty liver disease (MAFLD): a systematic review and meta-analysis","volume":"14","author":"Wang","year":"2022","journal-title":"Nutrients"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"e096598","DOI":"10.1136\/bmjopen-2024-096598","article-title":"Analysis of risk factors associated with metabolic-associated fatty liver disease from Suzhong region, China: a cross-sectional study","volume":"15","author":"Zhang","year":"2025","journal-title":"BMJ Open"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12876-025-03915-x","article-title":"Modified triglyceride-glucose indices as novel predictors of metabolic dysfunction-associated fatty liver disease in US adolescents: a nationally representative study from NHANES 2017-2020","volume":"25","author":"Zou","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.2169\/internalmedicine.1097-22","article-title":"Utility of indices obtained during medical checkups for predicting fatty liver disease in non-obese people","volume":"62","author":"Otsubo","year":"2023","journal-title":"Intern Med"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"e0331140","DOI":"10.1371\/journal.pone.0331140","article-title":"Nonlinear association between TyG-BMI and MAFLD: a cross-sectional study","volume":"20","author":"Wang","year":"2025","journal-title":"PLoS One"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"e0324483","DOI":"10.1371\/journal.pone.0324483","article-title":"Association of triglyceride glucose-body mass index (TyG-BMI) with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis","volume":"20","author":"Boushehri","year":"2025","journal-title":"PLoS One"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1043169","DOI":"10.3389\/fendo.2022.1043169","article-title":"The triglyceride and glucose index and risk of nonalcoholic fatty liver disease: a dose-response meta-analysis","volume":"13","author":"Ling","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.cgh.2017.04.040","article-title":"Histologic scores for fat and fibrosis associate with development of type 2 diabetes in patients with nonalcoholic fatty liver disease","volume":"15","author":"Bj\u00f6rkstr\u00f6m","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/j.cgh.2020.12.022","article-title":"Metabolic dysfunction-associated fatty liver disease and incident cardiovascular disease risk: a nationwide cohort study","volume":"19","author":"Lee","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ejca.2022.06.051","article-title":"Hepatocellular and extrahepatic cancers in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"173","author":"Thomas","year":"2022","journal-title":"Eur J Cancer"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"114827","DOI":"10.1016\/j.biopha.2023.114827","article-title":"Abnormalities of glucose and lipid metabolism in myocardial ischemia-reperfusion injury","volume":"163","author":"Tian","year":"2023","journal-title":"Biomed Pharmacother"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1788704\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:04:15Z","timestamp":1772003055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1788704\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":54,"alternative-id":["10.3389\/fnut.2026.1788704"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1788704","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"article-number":"1788704"}}